Apollo
Posted Date: Jul 22, 2019
- Investigator: Manish Anand
- Specialties: Nephrology, Transplant Nephrology
- Type of Study: Observational/Survey
The National Institutes of Health (NIH)-sponsored collaborative APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) is charged with prospectively assessing the effects of renal-risk variants (RRVs) in the apolipoprotein L1 gene (APOL1) on outcomes for kidneys from donors with recent African ancestry and the recipients of their kidneys, after deceased- and living-donor renal transplantation. For the purposes of APOLLO, recent African ancestry is defined as individuals with similar genetic make-up to those currently residing in Africa. APOLLO will also study the impact of APOL1 RRVs on the health of living kidney donors with recent African ancestry.
Criteria:
Living Kidney Donors With Self Reported Recent African Ancestry. Recipients Of A Kidney Transplant From An Eligible Living Or Deceased Donor With Recent African Ancestry.
Keywords:
Apol1
For More Information:
Kathleen Harrison
513-558-1880
harri3kh@ucmail.uc.edu